Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Color Diagnostics, |
RCV000583501 | SCV000686902 | likely benign | Hereditary cancer-predisposing syndrome | 2016-11-28 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000583501 | SCV001177155 | likely benign | Hereditary cancer-predisposing syndrome | 2019-05-10 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV001192796 | SCV001361154 | likely benign | not specified | 2020-01-31 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002529135 | SCV001709532 | likely benign | Familial adenomatous polyposis 1 | 2022-04-21 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV004001287 | SCV004839708 | likely benign | Classic or attenuated familial adenomatous polyposis | 2023-08-23 | criteria provided, single submitter | clinical testing | |
Myriad Genetics, |
RCV002529135 | SCV004931872 | benign | Familial adenomatous polyposis 1 | 2024-03-15 | criteria provided, single submitter | clinical testing | This variant is considered benign. This variant is a silent/synonymous amino acid change and it is not expected to impact splicing. |